Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 1, 1996
Proteases and their inhibitors are indicative in gestational diseaseM Kolben, A Lopens, J Bläser, et al.
Andrologia|March 1, 1985
On the teratogenesis of round-headed spermatozoa: investigations with antibodies against acrosin, an intraacrosomally located acrosin-inhibitor, and the outer acrosomal membraneS Flörke-Gerloff, W Krause, E Töpfer-Petersen, et al.
Geburtshilfe Und Frauenheilkunde|September 1, 1990
[Principles of physiologic and drug-induced cervix ripening--recent morphologic and biochemical findings]W Rath, R Osmers, B C Adelmann-Grill, et al.
Biochemistry|December 28, 1993
Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenaseT Kleine, S Bartsch, J Bläser, et al.
British Journal of Cancer|May 1, 1995
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancerM J Duffy, J Blaser, C Duggan, et al.
Biological Chemistry|August 11, 2000
Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1B E Bachmeier, A G Nerlich, P Boukamp, et al.
FEBS Letters|January 31, 1994
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic studyP Reinemer, F Grams, R Huber, et al.
The Biochemical Journal|June 26, 1998
Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecanF H Büttner, C E Hughes, D Margerie, et al.
Journal of Obstetrics and Gynaecology (Tokyo, Japan)|April 1, 1995
Biochemical events in cervical ripening dilatation during pregnancy and parturitionR G Osmers, B C Adelmann-Grill, W Rath, et al.
European Journal of Biochemistry|March 15, 1995
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug designF Grams, P Reinemer, J C Powers, et al.
Pageof 17